E. Polverino (Barcelona, Spain), G. Limonard (Utrecht, Netherlands)
Non-invasive mechanical ventilation and mortality in immunocompromised patients hospitalized with pneumonia C. Johnson, M. Metersky, A. Anzueto, E. Mortensen (Dallas, Farmington, San Antonio, United States Of America)
| |
Efficacy and safety of bronchial artery embolization for the control of hemoptysis in patients with mycobacterium avium complex lung disease K. Okuda, M. Kawashima, K. Masuda, J. Suzuki, N. Ohshima, H. Matsui, A. Yamane, A. Tamura, H. Nagai, S. Akagawa, K. Ohta (Kiyose City, Japan)
| |
A peripheral HRV-16-driven fingerprint is enriched in severe asthma patients in absence of an active exacerbation P. Branigan, R. Turner, A. Stojmirovic, M. Loza, A. Delvecchio, S. Marciniak, N. Peffer, P. Silkoff, R. Dobrin, F. Baribaud (Spring House, Charlottesville, United States Of America)
| |
Immunoglobulin G subclass deficiency in adult patients with chronic obstructive lung diseases J. H. Kim, S. Park, Y. I. Hwang, S. H. Jang, K. S. Jung, Y. S. Sim, T. R. Shin, S. M. Park, D. G. Kim (Anyang, Seoul, Republic Of Korea)
| |
Hypertonic saline in children with bronchiolitis Y. Gorinova, O. Simonova, Y. Lashkova, M. Bakradze (Moscow, Russian Federation)
| |
Non CF bronchiectasis: The effect of inhaled antibiotics (tobramycin and colistin) in patients with pseudomonas aeruginosa K. Dimakou, C. Triantafillidou, K. Tsikritsaki, A. Gousiou, A. Dervas, M. Toumbis (Athens, Greece)
| |
Rheumatoid arthritis and bronchiectasis: A multicentre study assessing pulmonary disease severity using the bronchiectasis severity index (BSI) A. De Soyza, J. Davison, M. McDonnell, E. Perry, S. Aliberti, P. Goeminne, J. Chalmers, A. Hill (Newcastle upon Tyne, Barnstable, Dundee, Edinburgh, United Kingdom; Galway, Ireland; Milan, Italy; Leuven, Belgium)
| |
The value of semi-quantitative mycobacterial cultures for predicting culture conversion during MAC lung disease therapy D. Griffith, J. Adjemian, B. Brown-Elliott, J. Philley, D. R. Prevots, S. Hunsberger, C. Gaston, K. Olivier, R. Wallace (Tyler, Bethesda, United States Of America)
| |
Development of the QOL-PCD: A cross-cultural patient-reported outcome measure for adults with primary ciliary dyskinesia L. Behan, A. DunnGalvin, A. L. Quittner, A. Alpern, N. Botting, M. P. Carroll, F. Copeland, M. R. Knowles, M. W. Leigh, M. Manion, T. Morelli, J. S. Lucas (Southampton, Milton Keynes, United Kingdom; Cork, Ireland; Coral Gables, Chapel Hill, Minneapolis, United States Of America)
| |
Lung function testing in children with airway disease: Does their performance deviate from healthy LUNOKID children? A. Hüls, U. Krämer, A. Schuster, M. Wisbauer, M. Gappa, C. Müller-Brandes, G. Seitner-Sorge, A. von Berg, B. Hoffmann, D. Berdel (Düsseldorf, Wesel, Hanover, Germany)
| |
Validation of a visual analogue score (LRTI-VAS) in non-CF bronchiectasis J. Altenburg, K. Wortel, T. Van der Werf, W. Boersma (Alkmaar, Groningen, Netherlands)
| |
Effects of a highly selective CXCR3 antagonist in two murine models of lung inflammation A. Vidal, C. Wikell, I. Dainty (Mölndal, Sweden)
| |
Viral and bacterial etiologies in acute exacerbation of COPD detected using a multiplex real-time polymerase chain reaction K. Shimizu, Y. Yoshii, M. Morozumi, N. Chiba, K. Ubukata, H. Uruga, S. Hanada, S. Ito, N. Takasaka, H. Hara, T. Numata, M. Kawaishi, J. Araya, Y. Kaneko, K. Nakayama, K. Kuwano (Tokyo, Japan)
| |
Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE) S. Lonni, J. D. Chalmers, A. Bignamini, G. Suigo, G. Bonaiti, S. Annoni, P. Faverio, A. Colzani, A. Pesci, A. T. Hill, S. Aliberti (Milan, Italy; Dundee, Edinburgh, United Kingdom)
| |
Differential ion mobility spectrometry for the discrimination of bacteria in vitro C. Steppert, I. Steppert, S. Schimanski, G. Becher (Bayreuth, Coburg, Bernau, Germany)
| |
Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia R. Marçôa, M. Dias, D. Coutinho, M. Mota, M. Guimarães, T. Shiang (Vila Nova de Gaia, Portugal)
| |
Venous central line catheter management in respiratory semi-intensive care unit: The way to zero central line-associated bloodstream infections (CLABSIs) – A randomized controlled trial R. Inchingolo, A. Smargiassi, G. Pasciuto, G. Corbo, M. Cavalletti, G. Montemurro, D. Magnini, G. Scoppettuolo, R. Torelli, T. Spanu, M. Sanguinetti, S. Valente (Rome, Italy)
| |
Detection of invasive aspergillosis by an electronic nose platform: Preliminary data in a validation cohort M. G. Gerritsen, P. Brinkman, K. de Heer, L. D. J. Bos, C. E. Visser, T. van der Bruggen, M. C. Minnema, P. J. Sterk, M. H. J. van Oers (Amsterdam, Utrecht, Netherlands)
| |